NGVT - Ingevity Corporation
NEXT EARNINGS:
Feb 25, 2026
(today)
EPS Est: $0.74
|
Rev Est: $257.3M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$67.50
DETAILS
HIGH:
$70.00
LOW:
$65.00
MEDIAN:
$67.50
CONSENSUS:
$67.50
DOWNSIDE:
5.09%
Market Cap:
2.59B
Volume:
192,286
Avg Volume:
312,376
52 Week Range:
28.49-77.46
Sector:
Basic Materials
Industry:
Chemicals - Specialty
Beta:
1.34
Last Dividend:
$N/A
Exchange:
NYSE
Country:
US
Employees:
1,600
IPO Date:
2016-05-03
EPS (TTM):
-11.85
P/E Ratio:
-3.44
Revenue (TTM):
1.41B
Total Assets:
2.02B
Total Debt:
1.45B
Cash & Equiv:
68.00M
Rev Growth (5Y):
1.7%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
-20.5%
ROCE:
-24.9%
Debt/Equity:
7.45
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-05 | $1.31 | $0.68 | +92.6% | $333.1M | $257.3M | +29.5% |
| 2025-08-04 | $1.39 | $1.02 | +36.3% | $365.1M | $372.0M | -1.9% |
| 2025-05-05 | $0.99 | $0.74 | +33.8% | $284.0M | $285.5M | -0.5% |
| 2025-02-18 | $0.95 | $0.29 | +227.6% | $298.8M | $328.2M | -9.0% |
| 2024-10-29 | $1.10 | $0.60 | +83.3% | $376.9M | $310.8M | +21.3% |
| 2024-07-31 | $1.01 | $1.05 | -3.8% | $390.6M | $407.6M | -4.2% |
| 2024-05-01 | $0.52 | $0.37 | +40.5% | $340.1M | $318.9M | +6.7% |
| 2024-02-21 | $0.21 | $-0.13 | +261.5% | $371.7M | $332.3M | +11.9% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.41B | 1.69B | 1.67B | 1.39B | 1.22B | 1.29B | 1.13B | 972.40M | 908.30M | 968.00M | 1.04B | 980.00M |
| Net Income | (430.30M) | (5.40M) | 211.60M | 118.10M | 181.40M | 183.70M | 169.10M | 126.30M | 35.20M | 80.00M | 129.00M | 119.00M |
| EPS | -11.85 | -0.15 | 5.54 | 2.97 | 4.39 | 4.39 | 4.03 | 3.00 | 0.83 | 1.89 | 3.07 | 2.83 |
| Total Assets | 2.02B | 2.62B | 2.74B | 2.47B | 2.33B | 2.14B | 1.32B | 930.30M | 832.80M | 782.00M | 718.00M | 593.00M |
| Total Debt | 1.45B | 1.53B | 1.53B | 1.32B | 1.34B | 1.23B | 741.20M | 444.00M | 481.30M | 89.00M | 89.00M | 86.00M |
| Cash & Equivalents | 68.00M | 95.90M | 76.70M | 275.40M | 257.70M | 56.50M | 77.50M | 87.90M | 30.50M | 32.00M | 20.00M | 12.00M |
| Operating Cash Flow | 128.60M | 205.10M | 313.40M | 293.30M | 352.40M | 275.70M | 252.00M | 174.30M | 127.90M | 73.00M | 143.00M | 137.00M |
| Free Cash Flow | 51.00M | 95.30M | 170.90M | 189.50M | 246.50M | 160.90M | 158.10M | 121.70M | 71.20M | (29.00M) | 42.00M | 74.00M |
| FCF per Share | 1.40 | 2.61 | 4.44 | 4.76 | 5.97 | 3.85 | 3.76 | 2.89 | 1.69 | -0.69 | 1.00 | 1.76 |
| Book Value | 195.20M | 631.40M | 698.30M | 673.80M | 642.10M | 530.80M | 339.60M | 277.70M | 134.60M | 517.00M | 417.00M | 326.00M |
| Cash & ST Investments | 68.00M | 95.90M | 76.70M | 275.40M | 257.70M | 56.50M | 77.50M | 87.90M | 30.50M | 32.00M | 20.00M | 12.00M |
| ROC Equity | -2.20 | -0.01 | 0.30 | 0.18 | 0.28 | 0.35 | 0.50 | 0.45 | 0.26 | 0.15 | 0.31 | 0.37 |